Hone Health, a leading telehealth clinic specializing in preventative and proactive longevity care, announced that it crossed 300,000 patients tested, 55,000 patients treated, and completed a $33 million Series A funding round with participation by Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs, and Agent Capital. This brings Hone Health’s total funding to $39 million.
The new funding will drive the company’s expansion into proactive and preventative longevity care for men and women while supporting its commitment to regulatory compliance and patient safety.
In 2020, Hone Health was launched to meet the increasing demand for accessible, personalized hormone optimization solutions. And the platform offers a comprehensive approach and integrates telemedicine, at-home, and in-person lab testing for 40+ biomarkers and tailored treatment plans, all overseen by expert medical professionals starting at $129/month.
With this funding, Hone also acquired ivee, to introduce in-home healthcare services, enabling physicians and practitioners to deliver care directly to patients in their homes. And this expansion enhances patient access to high-quality, personalized treatment while underscoring Hone Health’s commitment to safety and innovation in healthcare.
Hone’s technology is evolving to provide a multi-faceted care model that offers personalized protocols that combine medications, supplements, diet, exercise, stress reduction, and sleep guidance with community support to improve patients’ healthspan or quality of existence. The goal of care is first to alleviate any pre-existing symptoms immediately and then begin building lifestyle behaviors that slowly reverse the onset of chronic diseases like diabetes, cardiovascular disease, cancer, and dementia (otherwise known as the four horsemen) as popularized by expert physician Peter Attia.
Hone’s patient engine and proprietary EMR collected one of the most complete data sets on hormones globally and looks to expand and publish insights into other hugely underserved categories such as menopause, thyroid, and longevity care.
Hone Health is now poised to expand its scope, offering a broader range of proactive and preventative healthcare services. This investment will allow the company to address a wider array of health needs by utilizing its expertise in telemedicine and personalized treatment plans.
Some of the other notable angel investors that participated are Codie Sanchez, Paul and Michael Rabil (Founder of PLL), Mark & Matt Wan (Founder of Momentus), Anthony Pompliano, Austin Reif (Founder of Morning Brew), Shaan Puri, Sam Parr (Founder of The Hustle), Nikita Bier (Founder of TBH/Gas), and Fasha Majoor.
KEY QUOTES:
“Securing this investment is a pivotal moment for Hone Health. It allows us to capitalize on the shift from the broken primary care model to one that helps people live longer while staying healthy as they age. With this new capital, we’ll push the boundaries of innovation, broaden our reach, and equip both men and women with the resources to achieve optimal health in midlife and beyond. We are thrilled to partner with our investors to advance Hone Health’s mission to change the narrative around aging. The next decade will completely rewrite how we live our life from our 30s well into our 100s.”
- Saad Alam, Co-founder and CEO of Hone Health
“Hone Health has quickly emerged as a leader in men’s health, prioritizing patient safety and delivering a unique, comprehensive solution that addresses critical market needs. We are excited to support their next phase of growth as they continue to expand their footprint into longevity and holistic healthcare.”
- Ted Maidenberg, partner from Tribe Ventures
